US81577F3073 - Common Stock
SEELOS THERAPEUTICS INC
NASDAQ:SEEL (7/26/2024, 7:00:02 PM)
After market: 0.45 +0.01 (+2.27%)0.44
-0.03 (-6.6%)
Seelos Therapeutics Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in New York City, New York and currently employs 10 full-time employees. Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm is engaged in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The firm operates under one segment which develops pharmaceutical products. The firm's programs include SLS-002 for the potential treatment of acute suicidal ideation and behavior (ASIB) in patients with major depressive disorder (MDD) and SLS-005 for the potential treatment of amyotrophic lateral sclerosis (ALS) and spinocerebellar ataxia (SCA). SLS-002 is intranasal racemic ketamine with two investigational new drug applications (INDs). SLS-005 is used for the potential treatment of Sanfilippo Syndrome. SLS-005 is IV trehalose, a protein stabilizer that crosses the blood-brain barrier and activates autophagy and the lysosomal pathway. The firm's ongoing preclinical programs include SLS-004, SLS-006, and SLS-007.
SEELOS THERAPEUTICS INC
300 Park Avenue, 2nd Floor
New York City NEW YORK 10022
P: 16462932100
CEO: Raj Mehra
Employees: 10
Website: https://seelostherapeutics.com/
Which stocks are moving on Friday?
Which stocks have an unusual volume on Thursday?
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
Pre-market stock movers are worth checking out on Wednesday as we break down all of the biggest news worth reading this morning!
These psychedelic drug stocks aren't as radical as once thought as institutional awareness and emphasize on their potential increases.
/PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of...
Here you can normally see the latest stock twits on SEEL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: